Insights

Strategic Partnerships Clinigen is actively expanding its partner ecosystem, including a strategic collaboration with Tepsivo and a minority stake investment. This signals openness to co‑developed solutions and PV services collaborations that could open cross‑sell opportunities for integrated clinical supply, PV, and digital services.

Expanded Access Recent activity includes managing exclusive supply and distribution for Santhera’s AGAMREE in non‑core markets, highlighting Clinigen’s strength in global distribution and controlled access programs that can be leveraged to pitch broader access solutions to mid‑sized biopharma clients seeking international reach.

Rare Disease Focus NaviGATE launched to support rare disease patients and advocates, indicating a strategic emphasis on patient access programs and educational initiatives that can be bundled with managed access and clinical supply services to attract sponsors focusing on underserved patient segments.

Global Distribution Footprint Clinigen’s model centers on global supply, clinical materials and managed access, presenting a clear value proposition for sponsors needing compliant international logistics, local pharmacovigilance and country‑level market access solutions as part of a single vendor ecosystem.

Financial Scale Signals With revenue in the range of 100M to 250M and peers in similar service spaces, Clinigen sits in a competitive mid‑market bracket where mid‑sized biopharma companies and CROs may seek scalable, end‑to‑end solutions to accelerate launches and navigate complex regulatory environments.

Similar companies to Clinigen

Clinigen's Email Address Formats

Clinigen uses at least 3 email formats:
Clinigen Email FormatsExamplePercentage
First.Last@clinigengroup.comJohn.Doe@clinigengroup.com
86%
FLast@clinigengroup.comJDoe@clinigengroup.com
13%
First.Middle@clinigengroup.comJohn.Michael@clinigengroup.com
1%

Frequently Asked Questions

What is Clinigen's phone number?

Minus sign iconPlus sign icon
You can contact Clinigen's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Clinigen's stock symbol?

Minus sign iconPlus sign icon
Clinigen is a publicly traded company; the company's stock symbol is CLIN.L.

What is Clinigen's official website and social media links?

Minus sign iconPlus sign icon
Clinigen's official website is clinigen.com and has social profiles on LinkedIn.

How much revenue does Clinigen generate?

Minus sign iconPlus sign icon
As of October 2026, Clinigen's annual revenue is estimated to be $100M - $250M.

What is Clinigen's SIC code and NAICS code?

Minus sign iconPlus sign icon
Clinigen's SIC code is 8071 - Medical Laboratories and NAICS code is 54 - Professional, Scientific, and Technical Services.

How many employees does Clinigen have currently?

Minus sign iconPlus sign icon
As of October 2026, Clinigen has approximately 697 employees across 6 continents, including Europe, North America and Asia. Key team members include Chief Executive Officer (acting): V. S., Chief Information Officer: M. F. and Chief People Officer: G. S. M. Explore Clinigen's employee directory with LeadIQ.

What industry does Clinigen belong to?

Minus sign iconPlus sign icon
Clinigen operates in the Professional Services industry.

What is Clinigen's email format?

Minus sign iconPlus sign icon
Clinigen's email format typically follows the pattern of First.Last@clinigengroup.com. Find more Clinigen email formats with LeadIQ.

When was Clinigen founded?

Minus sign iconPlus sign icon
Clinigen was founded in 2010.
Clinigen logo

Clinigen

Professional ServicesEngland, United Kingdom501-1000 Employees

Clinigen is a global specialist in pharmaceutical services, based in London, England. It operates in the pharmaceutical manufacturing sector, offering a suite of services that spans clinical services, product access and commercialization, pharmacovigilance, and regulatory affairs aimed at speeding patient access to medicines worldwide. The company supports pharmaceutical clients and healthcare systems by coordinating end-to-end activities—from development and sourcing to supply, distribution, and post-market safety monitoring—across diverse markets.

In January 2025, Clinigen announced a strategic partnership with Tepsivo and acquired a minority stake in the digital pharmacovigilance provider. The collaboration highlights a focus on strengthening safety monitoring and regulatory support as part of Clinigen’s broader service offering. Clinigen is headquartered in London and maintains a global footprint in the pharmaceutical services landscape.

Section iconCompany Overview

Phone number
SIC Code
8071 - Medical Laboratories
Stock Symbol
CLIN.L
NAICS Code
54 - Professional, Scientific, and Technical Services
Founded
2010
Employees
501-1000

Section iconFunding & Financials

  • $100M - $250M

    Clinigen's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.